{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"large-cell-neuroendocrine-carcinoma","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"A usually aggressive carcinoma composed of large malignant cells which display neuroendocrine characteristics. It is characterized by the presence of high mitotic activity and necrotic changes. The vast majority of cases are positive for neuron-specific enolase. Representative examples include lung, breast, cervical, and thymic neuroendocrine carcinomas.","mondoId":"MONDO:0005057","node":{"canonicalSlug":"large-cell-neuroendocrine-carcinoma","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"large cell neuroendocrine carcinoma","paragraphs":["A usually aggressive carcinoma composed of large malignant cells which display neuroendocrine characteristics. It is characterized by the presence of high mitotic activity and necrotic changes. The vast majority of cases are positive for neuron-specific enolase. Representative examples include lung, breast, cervical, and thymic neuroendocrine carcinomas."],"scope":"exact","source":"MONDO","upstream":"NCIT:C6875","url":"https://monarchinitiative.org/MONDO:0005057"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"neuroendocrine carcinoma","mondoId":"MONDO:0002120","slug":"neuroendocrine-carcinoma"},{"kind":"parent","label":"large cell carcinoma","mondoId":"MONDO:0005232","slug":null},{"kind":"child","label":"thymic large cell neuroendocrine carcinoma","mondoId":"MONDO:0003047","slug":"thymic-large-cell-neuroendocrine-carcinoma"},{"kind":"child","label":"ovarian large-cell neuroendocrine carcinoma","mondoId":"MONDO:0003049","slug":"ovarian-large-cell-neuroendocrine-carcinoma"},{"kind":"child","label":"breast large cell neuroendocrine carcinoma","mondoId":"MONDO:0003959","slug":"breast-large-cell-neuroendocrine-carcinoma"},{"kind":"child","label":"pulmonary large cell neuroendocrine carcinoma","mondoId":"MONDO:0003960","slug":null},{"kind":"child","label":"cervical large cell neuroendocrine carcinoma","mondoId":"MONDO:0006138","slug":"cervical-large-cell-neuroendocrine-carcinoma"},{"kind":"child","label":"pancreatic large cell neuroendocrine carcinoma","mondoId":"MONDO:0006347","slug":"pancreatic-large-cell-neuroendocrine-carcinoma"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/24145"}],"translation":"pending"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0005057\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>NCIT:C6875</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A usually aggressive carcinoma composed of large malignant cells which display neuroendocrine characteristics. It is characterized by the presence of high mitotic activity and necrotic changes. The vast majority of cases are positive for neuron-specific enolase. Representative examples include lung, breast, cervical, and thymic neuroendocrine carcinomas.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0005057\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"large-cell-neuroendocrine-carcinoma","sourceDocuments":[{"name":"MONDO: large cell neuroendocrine carcinoma","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0005057"}],"sourceNote":"","synonyms":["large cell NEC","large cell neuroendocrine carcinoma","large-cell neuroendocrine carcinoma","LCNEC"],"takeawayHtml":"","title":"large cell neuroendocrine carcinoma"},"schemaVersion":1}
